Vanguard Global Advisers’s Microbot Medical MBOT Stock Holding History
Bought
Maintained
Sold
Other funds holding MBOT
Vanguard Global Advisers's MBOT Position: Q3 2026 in Review
Vanguard Global Advisers held its Microbot Medical (MBOT) position steady in Q3 2026 at 19,971 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #3304.
Vanguard Global Advisers first reported a position in MBOT in Q1 2026 and has held it in 3 quarters since. The position peaked at $48.1K in Q1 2026. 74 funds tracked by Wall St. Rank hold MBOT as of Q3 2026.
- Vanguard Global Advisers held 19,971 shares of Microbot Medical worth $24K as of Q3 2026.
- Vanguard Global Advisers left its Microbot Medical share count unchanged in Q3 2026.
- Microbot Medical made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3304 holding.
- Vanguard Global Advisers first reported a position in Microbot Medical in Q1 2026 and has held it in 3 quarters since.
- Vanguard Global Advisers's Microbot Medical position peaked at $48.1K in Q1 2026.
- 74 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.